Here, we found that patients with SSc had significantly higher median levels of fractalkine [855.2 pg/ml (683.1–1,077)] than healthy controls [539.3 pg/ml (457.6–731); p = 0.0006] (Figure 2). Here, CX3CL1 is linked to systemic sclerosis.